Skip to main content
. Author manuscript; available in PMC: 2017 Sep 12.
Published in final edited form as: JAMA Oncol. 2016 Nov 1;2(11):1434–1440. doi: 10.1001/jamaoncol.2016.1820

Table 1.

Observed and expected rates for uterine corpus cancer in BRCA mutation carriers

Expected Observed O/E 95% Confidence Interval of the O/E p
All Corpus Cancers 4.30 8 1.86 0.80 – 3.67 0.09
 Endometrioid carcinoma 3.62 2 0.55 0.07 – 1.99 0.88
 Serous/serous-like carcinoma 0.34 5 14.8 4.81 – 34.6 <0.001
 Sarcoma 0.14 1 7.07 0.18 – 39.4 0.13